[Focus on antidiabetic biguanides].
D000138:Acidosis / Q000139:chemically induced*; D001645:Biguanides / Q000009:adverse effects*; D004335:Drug and Narcotic Control; D005060:Europe; D005602:France; D006801:Humans; D007773:Lactates; D010606:Pharmacy and Therapeutics Committee; D014481:United States
D001645:Biguanides; D007773:Lactates
Mise au point sur les biguanides antidiabétiques.